Ryan T Sullivan - Net Worth and Insider Trading
Ryan T Sullivan Net Worth
The estimated net worth of Ryan T Sullivan is at least $711,787 dollars as of 2024-11-29. Ryan T Sullivan is the General Counsel and Secretary of Intercept Pharmaceuticals Inc and owns about 21,889 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $415,891. Ryan T Sullivan is also the EVP and General Counsel of Anacor Pharmaceuticals Inc and owns about 30,132 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $295,896. Details can be seen in Ryan T Sullivan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan T Sullivan has not made any transactions after 2019-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ryan T Sullivan
Ryan T Sullivan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ryan T Sullivan owns 2 companies in total, including Intercept Pharmaceuticals Inc (ICPT) , and Anacor Pharmaceuticals Inc (ANAC) .
Click here to see the complete history of Ryan T Sullivan’s form 4 insider trades.
Insider Ownership Summary of Ryan T Sullivan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2019-11-19 | General Counsel and Secretary |
| ANAC | Anacor Pharmaceuticals Inc | 2016-06-24 | EVP and General Counsel |
Ryan T Sullivan Latest Holdings Summary
Ryan T Sullivan currently owns a total of 2 stocks. Among these stocks, Ryan T Sullivan owns 21,889 shares of Intercept Pharmaceuticals Inc (ICPT) as of November 19, 2019, with a value of $415,891 and a weighting of 58.43%. Ryan T Sullivan also owns 30,132 shares of Anacor Pharmaceuticals Inc (ANAC) as of April 29, 2016, with a value of $295,896 and a weighting of 41.57%.
Latest Holdings of Ryan T Sullivan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2019-11-19 | 21,889 | 19.00 | 415,891 |
| ANAC | Anacor Pharmaceuticals Inc | 2016-04-29 | 30,132 | 9.82 | 295,896 |
Holding Weightings of Ryan T Sullivan
Ryan T Sullivan Form 4 Trading Tracker
According to the SEC Form 4 filings, Ryan T Sullivan has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 12,154 shares on November 19, 2019, which brought Ryan T Sullivan around $1 Million.
According to the SEC Form 4 filings, Ryan T Sullivan has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 3,125 shares on April 29, 2016, which brought Ryan T Sullivan around $207,281.
Insider Trading History of Ryan T Sullivan
- 1
Ryan T Sullivan Trading Performance
Ryan T Sullivan Ownership Network
Ryan T Sullivan Owned Company Details
What does Intercept Pharmaceuticals Inc do?
Who are the key executives at Intercept Pharmaceuticals Inc?
Ryan T Sullivan is the General Counsel and Secretary of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
Ryan T Sullivan Mailing Address
Above is the net worth, insider trading, and ownership report for Ryan T Sullivan. You might contact Ryan T Sullivan via mailing address: C/o Warner Chilcott Corporation, 100 Enterprise Drive, Rockaway Nj 07855.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
